Laxmi Organic Industries Limited announced the outcome of its Board Meeting held on January 29, 2026. The Board approved the Unaudited Standalone and Consolidated Financial Results for the 3rd Quarter and Nine Months ended December 31, 2025, along with the Limited Review Reports from the Statutory Auditors. The Board also approved the re-appointment of Dr. Rajiv Banavali (DIN: 09128266) as an Independent Director for a second term of two years, effective from May 18, 2026, until May 17, 2028. This re-appointment is based on the recommendation of the Nomination and Remuneration Committee and is subject to the approval of the Company's Members. A postal ballot notice will be issued to shareholders to seek their approval for this re-appointment. Dr. Banavali brings extensive experience in the chemicals sector, with over 38 years in research and leadership roles, including his previous position as Senior Vice President, Science & Innovation at WestRock Corporation in the United States. He holds degrees in chemistry and a Ph.D. from the University of Missouri. He is not related to any of the Board members and is not debarred from holding the office of Director by any SEBI order.
